Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms

Posted on July 20, 2022

Read full report

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

May 15, 2026

Healing NETS Summit

April 30, 2026

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

March 31, 2026

Will Norman Nurse Webinar #2

March 24, 2026